Tissue factor in ulcerative colitis, with and without concomitant primary sclerosing cholangitis

Background: Ulcerative colitis (UC) in patients with the severe disease primary sclerosing cholangitis (PSC) constitutes a distinct clinical phenotype (PSC-UC) with a high incidence of colorectal cancer. Today, PSC-UC diagnosis is built on clinical observations only. Tissue factor (TF) has a potenti...

Full description

Saved in:
Bibliographic Details
Published inUpsala journal of medical sciences Vol. 124; no. 4; pp. 238 - 245
Main Authors Vessby, Johan, Lampinen, Maria, Åberg, Mikael, Rorsman, Fredrik, Siegbahn, Agneta, Wanders, Alkwin, Carlson, Marie
Format Journal Article
LanguageEnglish
Published England Taylor & Francis 02.10.2019
Upsala Medical Society
Subjects
Online AccessGet full text
ISSN0300-9734
2000-1967
2000-1967
DOI10.1080/03009734.2019.1689209

Cover

More Information
Summary:Background: Ulcerative colitis (UC) in patients with the severe disease primary sclerosing cholangitis (PSC) constitutes a distinct clinical phenotype (PSC-UC) with a high incidence of colorectal cancer. Today, PSC-UC diagnosis is built on clinical observations only. Tissue factor (TF) has a potential use in UC diagnostics, and also in colorectal cancer prognostication. Here we evaluate TF expression in an inflammatory bowel disease (IBD) cohort, with special focus on differences between UC and PSC-UC patients. Materials and methods: Colonic biopsies from UC (n = 23), PSC (n = 24), and healthy controls (n = 11) were stained for TF by immunohistochemistry. Mononuclear cell contribution to TF expression was verified using flow cytometry. Results: TF was distributed at three distinct colonic locations: in subepithelial pericryptal sheath cells, in mononuclear cells, and in the intestinal stroma. In contrast to UC-where inflammation was accompanied with TF up-regulation-PSC-UC activity remained low during inflammation. Stromal TF positivity was found exclusively in ongoing inflammation. Conclusion: Our study provides additional support for a divergent pathogenesis in PSC-UC, with an inflammatory environment that differs from classical UC. Stromal TF emerges as a new marker of colonic inflammation.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Supplemental data for this article can be accessed here.
ISSN:0300-9734
2000-1967
2000-1967
DOI:10.1080/03009734.2019.1689209